COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67 (Q84088624)
Jump to navigation
Jump to search
scientific article published on 22 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67 |
scientific article published on 22 April 2010 |
Statements
COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67 (English)
Elin Richardsen
Rebecca Dale Uglehus
Jan Due
Christer Busch
Lill-Tove Busund